Last reviewed · How we verify

NCT05210673

Enhanced Recovery for Patients Undergoing Radical Cystectomy.

Completed NA Last updated 11 February 2022
What this trial tests

NA trial testing ERAS in Post Procedural Discharge in 50 participants. Completed in 30 September 2021.

Timeline
1 September 2019
Primary endpoint
30 September 2021
30 September 2021

Quick facts

Lead sponsorMenoufia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment50
Start date1 September 2019
Primary completion30 September 2021
Estimated completion30 September 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Menoufia University

Who can join

Adults 40 to 85, any sex, with Post Procedural Discharge. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators hypothesize that with the use of enhanced recovery of surgery (ERAS), the postoperative hospital stay after radical cystectomy is reduced, and also postoperative complications are decreased.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ERAS

Trials testing the same drug.

Other Menoufia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05210673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing